Today is the tenth annual observance of Rare Disease Day, a day that brings awareness and highlights the importance of research and treatment of rare..
Our webinar, "Importance of Feasibility Timelines and When to Accept/Decline a Study?" highlighted factors to consider when accepting/declining a..
If you attended our webinar, Build Your Site Brand and Boost Patient Recruitment, you now know the benefits of branding your site and studies. Branding..
Despite the fact that there are over 5 million Americans suffering from Alzheimer’s disease, recruiting patients for trials is particularly..
An estimated 1 out of every 5,000 experimental compounds achieve FDA approval, and bring medial products to market costs about $1.3 billion...
Health literacy doesn’t just mean the ability to read and write; it’s the degree to which individuals can understand, communicate, and act upon health..
ClinEdge was a premier exhibitor at this year's 2016 Site Solutions Summit. The Summit offers a unique opportunity for attendees from sites and..
One of the diseases getting the most attention for clinical trials recently is Alzheimer’s disease. There have been several exciting developments in..
Each of these mobile applications brings the convenience of health services directly to patients through their mobile devices. Although not all have..